Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts This week, 27 April 2025: Treatment-resistant hypertension Influenza transmission Nanoplastics in human brains Malaria elimination Chikungunya vaccine

Gastric Cancer

Free Subscription 21.04.2025 5 BMC Cancer 4 BMC Gastroenterol 2 Br J Cancer 1 Dig Dis Sci 2 Eur J Surg Oncol 1 Gut 1 J Cancer Res Clin Oncol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. ZHANG C, Wang T, Yuan J, Wang T, et al
   Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.
   BMC Cancer. 2025;25:674.
   PubMed         Abstract available
   
   
2. BABA K, Suzuki N, Imamura CK, Booka E, et al
   A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.
   BMC Cancer. 2025;25:675.
   PubMed         Abstract available
   
   
3. BU S, Wang S, Wang T, Xing H, et al
   Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer.
   BMC Cancer. 2025;25:731.
   PubMed         Abstract available
   
   
4. FU M, Wang X, Zhou J, Wang J, et al
   Incidence and risk factors of sarcopenia in gastric cancer patients: a meta-analysis and systematic review.
   BMC Cancer. 2025;25:711.
   PubMed         Abstract available
   
   
5. WU GF, He CH, Xi WT, Zhai WB, et al
   Sarcopenia defined by the global leadership initiative in sarcopenia (GLIS) consensus predicts adverse postoperative outcomes in patients undergoing radical gastrectomy for gastric cancer: analysis from a prospective cohort study.
   BMC Cancer. 2025;25:679.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

6. LI X, Lei T, Fu L, Gao R, et al
   Meta-analysis of the efficacy of applying reduced surgery for the treatment of asymptomatic unresectable advanced gastric cancer.
   BMC Gastroenterol. 2025;25:271.
   PubMed         Abstract available
   
   
7. WANG R, Zeng H, Shi M, Wu Y, et al
   Dynamic variations in peripheral blood indices and their association with efficacy and adverse reactions of pd- 1 inhibitor combined chemotherapy in patients with advanced gastric cancer.
   BMC Gastroenterol. 2025;25:264.
   PubMed         Abstract available
   
   
8. LU J, Xiao Y, Wang Q, Chen F, et al
   Development and verification of a radiomics model to forecast Ki67 index and prognosis in advanced gastric tubular adenocarcinoma.
   BMC Gastroenterol. 2025;25:260.
   PubMed         Abstract available
   
   
9. YE W, Zhang X, Tang Z, Hu Y, et al
   Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer.
   BMC Gastroenterol. 2025;25:256.
   PubMed         Abstract available
   
   

   
   Br J Cancer

10. LI J, Tao M, Liu L, Liu C, et al
    Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer.
    Br J Cancer. 2025 Apr 17. doi: 10.1038/s41416-025-03015.
    PubMed         Abstract available
    
    
11. LU J, Chen Y, Liu X, Wang J, et al
    Artificial intelligence-driven microRNA signature for early detection of gastric cancer: discovery and clinical functional exploration.
    Br J Cancer. 2025 Apr 15. doi: 10.1038/s41416-025-02984.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

12. ZHENG W, Ge Z, Wu Q, Wan H, et al
    Olaparib Combined with Anti-PD1 Enhances Immunotherapy of Gastric Cancer Via NF-kappaB/c-Myc/PD-L1 Signaling.
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09021.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

13. AMEYA KP, Sekar D
    Letter to the editor: Outcomes of intraperitoneal chemotherapy for the treatment of gastric cancer with peritoneal metastasis: A comprehensive systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110026.
    PubMed        
    
    
14. LIU Y, Chen Y, Shu J, Zhang Z, et al
    Dual-energy CT for predicting progression-free survival of locally advanced gastric cancer after gastrectomy: Insights into tumor angiogenesis.
    Eur J Surg Oncol. 2025;51:110017.
    PubMed         Abstract available
    
    

    
    Gut

15. YAMADA H, Abe S, Charvat H, Ando T, et al
    Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study.
    Gut. 2025 Apr 15:gutjnl-2025-335039. doi: 10.1136/gutjnl-2025-335039.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

16. CHENG G, Wusiman L, Song D, Zhang W, et al
    Silencing PPP2R1A inhibits the progression of gastric cancer cells.
    J Cancer Res Clin Oncol. 2025;151:142.
    PubMed         Abstract available
    
    

    
    PLoS One

17. PARK J, Kim DY, Suh M, Kim YH, et al
    Assessing gastric cancer risk through longitudinal health check-up data: Insights from a national cohort study in South Korea.
    PLoS One. 2025;20:e0312861.
    PubMed         Abstract available
    
    
18. LIU DS, Allan Z, Tie J, Hall K, et al
    Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment.
    PLoS One. 2025;20:e0318615.
    PubMed         Abstract available
    
    
19. 
    Retraction: Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress.
    PLoS One. 2025;20:e0322907.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.